$0.95 0.00 (%) Aveo Pharmaceuticals Inc - NASDAQ

Jun. 24, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. EXCLUSIVE: AVEO CEO Explains How New Partnership Will Address $500 Million Opportunity Overseas

    Benzinga | Dec. 21, 2015 | 13:39PM EST
  2. Mid-Morning Market Update: Markets Open Higher; Neogen Earnings Miss View

    Benzinga | Dec. 21, 2015 | 09:55AM EST
  3. AVEO and EUSA Pharma Announce Exclusive Licensing Agreement for Tivozanib in Europe

    Benzinga | Dec. 21, 2015 | 06:30AM EST
  4. Repeat Performance In Aveo Pharmaceuticals After Spike In Price

    Benzinga | Aug. 17, 2015 | 13:34PM EST
  5. Morning Market Gainers

    Benzinga | Aug. 17, 2015 | 09:45AM EST
  6. Benzinga's Top #PreMarket Gainers

    Benzinga | Aug. 17, 2015 | 08:08AM EST
  7. US Stock Futures Flat Ahead Of Housing Data

    Benzinga | Aug. 17, 2015 | 07:29AM EST
  8. AVEO Announces Exclusive Worldwide License Agreement for, Development, Commercialization of AV-380 and Related Antibodies

    Benzinga | Aug. 17, 2015 | 06:02AM EST
  9. This Week's First IPO: Global Blood Therapeutics Developing Drugs For Diseases Affecting Few

    Benzinga | Aug. 13, 2015 | 09:23AM EST
  10. Morning Market Losers

    Benzinga | Jun. 12, 2015 | 10:00AM EST
  11. Mid-Day Market Update: Sigma Designs Surges On Upbeat Results; Boulder Brands Shares Drop

    Benzinga | Jun. 10, 2015 | 13:05PM EST
  12. Morning Market Gainers

    Benzinga | Jun. 4, 2015 | 09:42AM EST
  13. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 4, 2015 | 08:16AM EST
  14. Morning Market Losers

    Benzinga | Jun. 3, 2015 | 09:52AM EST
  15. Benzinga's Top #PreMarket Losers

    Benzinga | Jun. 3, 2015 | 08:17AM EST
  16. Morning Market Gainers

    Benzinga | Jun. 2, 2015 | 09:42AM EST
  17. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 2, 2015 | 08:07AM EST
  18. Morning Market Gainers

    Benzinga | May. 22, 2015 | 09:46AM EST
  19. Benzinga's Top #PreMarket Gainers

    Benzinga | May. 22, 2015 | 08:20AM EST
  20. What's Up With The Delayed Reaction In Aveo Pharmaceuticals?

    Benzinga | May. 21, 2015 | 12:01PM EST
  21. Morning Market Gainers

    Benzinga | May. 21, 2015 | 09:49AM EST
  22. Morning Market Gainers

    Benzinga | May. 20, 2015 | 09:43AM EST
  23. AVEO Reports Presentation of Final Results of Extension Study 902, FDA Regulatory Feedback for Advancing Tivozanib in Renal Cell Carcinoma

    Benzinga | May. 20, 2015 | 07:03AM EST
  24. Klarman-Founded Baupost Group Increases Stake In eBay, Trims Micron and Citigroup In Q4

    Benzinga | Feb. 14, 2015 | 19:49PM EST
  25. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 4

    Benzinga | Jan. 13, 2015 | 11:34AM EST
  26. US Stock Futures Surge Ahead Of ADP Report, Fed Minutes

    Benzinga | Jan. 7, 2015 | 07:06AM EST
  27. US Stock Futures Slightly Higher; Dollar Surges Against Yen

    Benzinga | Nov. 11, 2014 | 07:04AM EST
  28. AVEO Enters into Research And Exclusive Option Agreement With Ophthotech For Tivozanib (VEGF inhibitor) For The Treatment Of Ocular Diseases

    Benzinga | Nov. 11, 2014 | 06:46AM EST
  29. AVEO Oncology Announces Lease Termination And Amendment To Debt Financing Facility

    Benzinga | Sep. 26, 2014 | 07:01AM EST
  30. 3 Biotech Stocks Backed By Big Money

    Benzinga | Jun. 16, 2014 | 14:27PM EST
  31. Morning Market Movers

    Benzinga | Apr. 10, 2014 | 09:42AM EST
  32. Stocks Hitting 52-Week Lows

    Benzinga | Apr. 7, 2014 | 10:35AM EST
  33. Earnings Scheduled For March 13, 2014

    Benzinga | Mar. 13, 2014 | 04:51AM EST
  34. Benzinga Weekly Preview: Ukraine Tension Likely To Drive Markets

    Benzinga | Mar. 7, 2014 | 16:11PM EST
  35. Stocks Hitting 52-Week Lows

    Benzinga | Dec. 16, 2013 | 10:35AM EST
  36. Stocks Hitting 52-Week Lows

    Benzinga | Dec. 13, 2013 | 10:15AM EST
  37. Morning Market Losers

    Benzinga | Dec. 13, 2013 | 10:09AM EST
  38. US Stock Futures Gain Ahead Of Producer Price Index

    Benzinga | Dec. 13, 2013 | 07:07AM EST
  39. AVEO Says Tivozanib Trial in Colorectal Cancer Unlikely to Meet Primary Endpoint

    Benzinga | Dec. 13, 2013 | 06:53AM EST
  40. Wild Card Wonders, Shopping for 52-Week Lows

    GuruFocus | Sep. 28, 2013 | 23:04PM EST
  41. Sure Hope You Ignored This Dude on Aveo Stock

    YCharts | Sep. 16, 2013 | 15:43PM EST
  42. Sleepy Sector Wakes Up - Billionaires Hold Biotechs in 52-week Low

    GuruFocus | Sep. 3, 2013 | 14:52PM EST
  43. Cutting Loose: Seth Klarman's Active Second Quarter Selling and Trimming

    GuruFocus | Aug. 14, 2013 | 19:51PM EST
  44. 13-F Alert: Baupost Group Adds AIG Shares and Microsoft Call Options

    Benzinga | Feb. 13, 2013 | 11:16AM EST
  45. A Peek Into The Market Before The Trading Starts

    Benzinga | Jan. 29, 2013 | 00:22AM EST
  46. AVEO, Astellas Announce Presentations of Tivozanib Clinical Data

    Benzinga | Jan. 28, 2013 | 23:51PM EST
  47. AVEO Pharmaceuticals Closes Public Offering

    Benzinga | Jan. 23, 2013 | 23:56PM EST
  48. Weekly CEO Buys Highlight: AVEO, ZAZA, TUES, TUES, FRAN, AKVA

    GuruFocus | Dec. 16, 2012 | 05:15AM EST
  49. AVEO Pharmaceuticals, Inc. (AVEO) CEO Ngoc Tuan Ha buys 75,000 Shares

    GuruFocus | Dec. 14, 2012 | 02:37AM EST
  50. A Peek Into The Market Before The Trading Starts

    Benzinga | Nov. 28, 2012 | 00:20AM EST
Trading Center